Side-by-side comparison of AI visibility scores, market position, and capabilities
Bethesda largest defense contractor (NYSE: LMT) ~$71B FY2024 revenue; F-35 $12.5B contract (Lots 18-19, ~300 fighters Sept 2025), Sikorsky Black Hawk, 122,000 employees competing with RTX and Northrop Grumman.
Lockheed Martin Corporation is a Bethesda, Maryland-based global aerospace, defense, security, and advanced technologies company — publicly traded on the New York Stock Exchange (NYSE: LMT) as an S&P 500 Industrials component — designing, developing, manufacturing, and sustaining advanced technology systems and services for the US government, US allies, and international defense customers through approximately 122,000 employees worldwide. Lockheed Martin is the world's largest defense contractor by revenue, generating approximately $71 billion in fiscal year 2024 revenue primarily from the US Department of Defense. The company's flagship program — the F-35 Lightning II stealth multirole fighter — is the costliest weapons program in US history, with total program lifetime cost exceeding $1.7 trillion through the 2070s. In September 2025, the Pentagon awarded Lockheed Martin a finalized $12.5 billion contract definitizing 148 F-35 Joint Strike Fighters from Lot 18 and adding scope for 148 additional fighters in Lot 19 — building on the initial $11.8 billion contract from December 2024 — continuing the F-35's multi-decade production run for US Air Force (F-35A), US Navy (F-35C), and US Marine Corps (F-35B STOVL) along with 8 international partner nations and 3 Foreign Military Sales customers. CEO Jim Taiclet leads Lockheed's digital transformation strategy — "21st Century Security" — integrating artificial intelligence, autonomous systems, advanced manufacturing, and network-centric warfare capabilities across Lockheed's platforms.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.